Outputs (2)

Critical appraisal of the clinical practice guideline for the management of dyslipidaemia and prevention of cardiovascular disease: AACE 2017 guidelines. (2019)
Journal Article
ALKHAWAJA, R.M., MADI, L., ALHAMOUD, E., ABDALLAH, I., JAVED, M., FAYEZ, H. and AL-ADAWI, R.M. 2019. Critical appraisal of the clinical practice guideline for the management of dyslipidaemia and prevention of cardiovascular disease: AACE 2017 guidelines. Journal of pharmaceutical health services research [online], 10(3), pages 383-388. Available from: https://doi.org/10.1111/jphs.12302

Objective: This study aims to appraise 2017 AACE Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease by using Appraisal of Guidelines for Research and Evaluation II (AGREE II) tool. Method: A total of seven investigator... Read More about Critical appraisal of the clinical practice guideline for the management of dyslipidaemia and prevention of cardiovascular disease: AACE 2017 guidelines..

Assessment of dapagliflozin effectiveness as add-on therapy for the treatment of type 2 diabetes mellitus in a Qatari population. (2019)
Journal Article
AL ADAWI, R.M., JASSIM, Z., ELGAILY, D., ABDELAZIZ, H., SREE, B. and MOHAMED IBRAHIM, M.I. 2019. Assessment of dapagliflozin effectiveness as add-on therapy for the treatment of type 2 diabetes mellitus in a Qatari population. Scientific reports [online], 9, article 6864. Available from: https://doi.org/10.1038/s41598-019-43052-6

The effectiveness of dapagliflozin in the management of type-2 diabetes mellitus (T2-DM) is an essential issue for establishing a basis for prescribing dapagliflozin. This study aimed to assess the effectiveness of dapagliflozin in combination with o... Read More about Assessment of dapagliflozin effectiveness as add-on therapy for the treatment of type 2 diabetes mellitus in a Qatari population..